Viaderma is selling at 4.0E-4 as of the 6th of February 2026; that is No Change since the beginning of the trading day. The stock's lowest day price was 4.0E-4. Viaderma has more than 67 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 8th of November 2025 and ending today, the 6th of February 2026. Click here to learn more.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 137.32 K outstanding shares. More on Viaderma
Viaderma [VDRM] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 82.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viaderma's market, we take the total number of its shares issued and multiply it by Viaderma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Viaderma conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 137.32 K outstanding shares.
Viaderma currently holds about 13.08 K in cash with (167.36 K) of positive cash flow from operations.
Check Viaderma Probability Of Bankruptcy
The company has Price to Book (P/B) ratio of 0.0. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viaderma had not issued any dividends in recent years. The entity had 1:50 split on the 6th of May 2014. ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Viaderma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 310 496 5744 or visit https://viadermalicensing.com.
Viaderma has some characteristics of a very speculative penny stock
Viaderma appears to be risky and price may revert if volatility continues
Viaderma has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Viaderma until it has trouble settling it off, either with new capital or with free cash flow. So, Viaderma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viaderma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viaderma to invest in growth at high rates of return. When we think about Viaderma's use of debt, we should always consider it together with cash and equity.
Viaderma reported the previous year's revenue of 44.69 K. Net Loss for the year was (1.52 M) with profit before overhead, payroll, taxes, and interest of 37.63 K.
Viaderma currently holds about 13.08 K in cash with (167.36 K) of positive cash flow from operations.
Viaderma Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 82.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viaderma's market, we take the total number of its shares issued and multiply it by Viaderma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Technical Drivers
As of the 6th of February, Viaderma has the Semi Deviation of 16.53, risk adjusted performance of 0.1662, and Coefficient Of Variation of 480.73. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viaderma, as well as the relationship between them. Please validate Viadermavariance, as well as the relationship between the value at risk and skewness to decide if Viaderma is priced more or less accurately, providing market reflects its prevalent price of 4.0E-4 per share. As Viaderma appears to be a penny stock we also recommend to double-check its total risk alpha numbers.
The output start index for this execution was zero with a total number of output elements of sixty-one. Viaderma Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Viaderma price patterns.
Viaderma Outstanding Bonds
Viaderma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viaderma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viaderma bonds can be classified according to their maturity, which is the date when Viaderma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Viaderma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viaderma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Viaderma's time-series forecasting models are one of many Viaderma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viaderma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Viaderma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Other Information on Investing in Viaderma Pink Sheet
Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.